Medtronic received information via literature that an (b)(6) year old male patient underwent a successful implantation of a medtronic 25-mm stentless aortic bioprosthetic valve (serial not reported).Twelve years postoperative the patient had significant dyspnea on exertion requiring multiple hospital admissions for congestive heart failure.Transthoracic echocardiography demonstrated severe structural valve deterioration of the prosthetic valve with mild to moderate stenosis and severe aortic insufficiency.Subsequently, the patient underwent a transapical approach procedure to implant a small non-medtronic bioprosthetic valve inside the previously implanted valve.The upper crown of the new valve was opened just above the aortic annulus to engage the degenerated leaflets of the previous valve, and pulled slightly ventricular before releasing the lower crown and sealing skirt to fully deploy the new valve.Postprocedural assessment confirmed an excellent result after valve-in-valve implantation, with no residual aortic insufficiency.Postoperatively the patient did well without complication.No additional adverse patient effects were reported.
|
(b)(4).Title: symetis valve implantation in failing freestyle with close proximity between coronary ostia and annulus authors: jeevan nagendran, md, phd, jorge catrip, md, pantelis diamantouros, md, patrick teefy, md, bob kiaii, md, ian chan, md, aas hish goela, md, david m.Holzhey, md, and michael w.A.Chu, md, med citation: ann thorac surg 2015;99:e87¿8.
|